tiprankstipranks
Janus Living, Inc. Class A (JAN)
:JAN
US Market

Janus Living, Inc. Class A (JAN) Price & Analysis

12 Followers

JAN Stock Chart & Stats

$23.70
$0.17(0.72%)
--

Janus Living, Inc. Class A News

JAN FAQ

What was Janus Living, Inc. Class A’s price range in the past 12 months?
Janus Living, Inc. Class A lowest stock price was $22.76 and its highest was $24.36 in the past 12 months.
    What is Janus Living, Inc. Class A’s market cap?
    Currently, no data Available
    When is Janus Living, Inc. Class A’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Janus Living, Inc. Class A’s earnings last quarter?
    Currently, no data Available
    Is Janus Living, Inc. Class A overvalued?
    According to Wall Street analysts Janus Living, Inc. Class A’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
      Does Janus Living, Inc. Class A pay dividends?
      Janus Living, Inc. Class A does not currently pay dividends.
      What is Janus Living, Inc. Class A’s EPS estimate?
      Janus Living, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Janus Living, Inc. Class A have?
      Janus Living, Inc. Class A has 187,222,990 shares outstanding.
        What happened to Janus Living, Inc. Class A’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Janus Living, Inc. Class A?
        Currently, no hedge funds are holding shares in JAN
        What is the TipRanks Smart Score and how is it calculated?
        Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

          Company Description

          Janus Living, Inc. Class A

          JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
          Popular Stocks